scispace - formally typeset
Open AccessJournal ArticleDOI

Crystal Engineering Approach To Forming Cocrystals of Amine Hydrochlorides with Organic Acids. Molecular Complexes of Fluoxetine Hydrochloride with Benzoic, Succinic, and Fumaric Acids

Reads0
Chats0
TLDR
A crystal engineering strategy for designing cocrystals of pharmaceuticals increases the probability of discovering useful cocry crystals and decreases the number of experiments that are needed by selecting API:guest combinations that have the greatest potential of forming energetically and structurally robust interactions.
Abstract
A crystal engineering strategy for designing cocrystals of pharmaceuticals is presented. The strategy increases the probability of discovering useful cocrystals and decreases the number of experiments that are needed by selecting API:guest combinations that have the greatest potential of forming energetically and structurally robust interactions. Our approach involves multicomponent cocrystallization of hydrochloride salts, wherein strong hydrogen bond donors are introduced to interact with chloride ions that are underutilized as hydrogen bond acceptors. The strategy is particularly effective in producing cocrystals of amine hydrochlorides with neutral organic acid guests. As an example of the approach, we report the discovery of three cocrystals containing fluoxetine hydrochloride (1), which is the active ingredient in the popular antidepressant Prozac. A 1:1 cocrystal was prepared with 1 and benzoic acid (2), while succinic acid and fumaric acid were each cocrystallized with 1 to provide 2:1 cocrystals of fluoxetine hydrochloride:succinic acid (3) and fluoxetine hydrochloride:fumaric acid (4). The presence of a guest molecule along with fluoxetine hydrochloride in the same crystal structure results in a solid phase with altered physical properties when compared to the known crystalline form of fluoxetine hydrochloride. On the basis of intrinsic dissolution rate experiments, cocrystals 2 and 4 dissolve more slowly than 1, and 3 dissolves more quickly than 1. Powder dissolution experiments demonstrated that the solid present at equilibrium corresponds to the cocrystal for 2 and 4, while 3 completely converted to 1 upon prolonged slurry in water.

read more

Citations
More filters
Journal ArticleDOI

Pharmaceutical Cocrystals and Their Physicochemical Properties

TL;DR: The advances made over the last 10 years pertaining to physical and chemical property improvements through pharmaceutical cocrystalline materials will be highlighted and discussed to draw closer the fields of crystal engineering and pharmaceutical sciences.
Journal ArticleDOI

Strategies to Address Low Drug Solubility in Discovery and Development

TL;DR: The article provides an integrated and contemporary discussion of current approaches to solubility and dissolution enhancement but has been deliberately structured as a series of stand-alone sections to allow also directed access to a specific technology where required.
Journal ArticleDOI

Drug Solubility: Importance and Enhancement Techniques

TL;DR: Various techniques are used for the enhancement of the solubility of poorly soluble drugs which include physical and chemical modifications of drug and other methods like particle size reduction, crystal engineering, salt formation, solid dispersion, use of surfactant, complexation, and so forth.
Journal ArticleDOI

Crystal engineering: from molecule to crystal.

TL;DR: This Perspective provides a brief historical introduction to crystal engineering itself and an assessment of the importance and utility of the supramolecular synthon, which is one of the most important concepts in the practical use and implementation of crystal design.
Journal ArticleDOI

Pharmaceutical Co-Crystals

TL;DR: This review addresses how crystal engineering has been applied to active pharmaceutical ingredients, API's, with emphasis upon how pharmaceutical co-crystals, a long known but little explored alternative to the four traditionally known forms of API, can be generated in a rational fashion.
References
More filters
Journal ArticleDOI

Supramolecular Synthons in Crystal Engineering—A New Organic Synthesis

TL;DR: In this article, the authors show that crystal engineering is a new organic synthesis, and that rather than being only nominally relevant to organic chemistry, this subject is well within the mainstream, being surprisingly similar to traditional organic synthesis in concept.
Journal ArticleDOI

Salt Selection and Optimisation Procedures for Pharmaceutical New Chemical Entities

TL;DR: In this article, a range of salts should be prepared for each new substance and their properties compared during a suitable pre-formulation program, where possible, where the salt form selected will influence other properties such as melting point, hygroscopicity, chemical stability, dissolution rate, solution pH, crystal form, and mechanical properties.
Journal ArticleDOI

Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids.

TL;DR: The results suggest that cocrystals of drug molecules have the possibility of achieving the higher oral bioavailability common for amorphous forms of water-insoluble drugs while maintaining the long-term chemical and physical stability that crystal forms provide.
Journal ArticleDOI

Crystal Engineering of the Composition of Pharmaceutical Phases: Multiple-Component Crystalline Solids Involving Carbamazepine

TL;DR: The carboxylic acid-pyridine supramolecular heterosynthon can be exploited to predictably generate binary crystalline phases involving rac-ibuprofen, rac-flurbiprofen or aspirin.
Journal ArticleDOI

Crystal structures of drugs: advances in determination, prediction and engineering

TL;DR: The different crystal forms of pharmaceuticals, the challenges that they present and recent advances in crystal structure determination are reviewed, and computational approaches for predicting crystal properties are discussed.
Related Papers (5)